HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
Martin Lupinetti, president and CEO of HealthShare Exchange, speaks on lessons learned about data quality and reaching seniors during the pandemic.
CMS says about 25% of the spend is fraudulent or being abused by providers, says Carol Howard, vice president of innovation and adoption at Janus Health.
The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.
Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.